Welcome to the PharmCast Research Store. Gain access to market leading research in your industry. You can browse through the portfolio of reports below or enter keywords in the search box to find the information you have been looking for.
  • Browse Reports & Briefs
  • Browse Company Profiles
  • Browse Industry Profiles
  • Latest News
Number of Employees

< 250 (30)

250 - 999 (22)

1,000 - 2,499 (20)

2,500 - 4,999 (29)

5,000 - 9,999 (56)

10,000 - 49,999 (113)

50,000+ (40)

Annual Revenue US$m

< 50 (19)

50 - 99 (7)

100 - 199 (8)

200 - 499 (20)

500 - 999 (11)

1,000 - 1,999 (45)

2,000+ (189)

Top stories

Antares doses first patient in Phase III testosterone deficiency study

Antares Pharma, Inc., a provider of parenteral pharmaceutical products, has dosed the first patient in a double-blind, multiple-dose, Phase III study to evaluate the efficacy and safety of QuickShot Testosterone, or QS T, administered subcutaneously once each week to testosterone-deficient adult males...more >>

Cubist Pharmaceuticals Q2 net income up

Cubist Pharmaceuticals, Inc., a biopharmaceutical company, has reported that net income for the second quarter ended June 30, 2014 was $24.03 million, or $0.3 per diluted share, compared to $15.24 million, or $0.23 per diluted share, for the second quarter ended June 30, 2013...more >>

Synta announces Phase III extension of acute myeloid leukemia study

Synta Pharmaceuticals Corp., a biopharmaceutical company, has announced the advancement of ganetespib into the Phase III extension of the AML LI-1 trial for acute myeloid leukemia, or AML, and high-risk myelodysplastic syndrome, or MDS...more >>

Boston Scientific launches new intravascular imaging system

Boston Scientific Corporation, a medical technology company, has launched the new POLARIS Imaging System for intravascular imaging...more >>